@drmohammedalo: 🚨 Most patients quit their statin or Repatha right around the time it actually starts working. They feel nothing for months. No energy boost. No number they can see. So they assume it is failing. But the data says otherwise. I am a cardiologist. I have hundreds of patients on lipid-lowering therapy, and I tell every single one the same thing before they start. 🩺 In VESALIUS-CV, patients on Repatha showed almost no difference in death rates for the first eighteen months. Risk reduction was essentially flat. 💓 Then something changed. After eighteen months, all-cause mortality dropped 20%. Cardiovascular death fell 27%. 🔬 That delay is not the drug failing. Plaque took decades to build in your arteries. It does not unwind in a financial quarter. Lowering LDL removes the fuel for new plaque and slowly stabilizes what is already there. That process takes time to show up as fewer heart attacks and fewer deaths. A patient who stays on therapy through year one with no obvious symptom change can still be cutting their future risk of death dramatically. That is the difference between quitting at month three and living past year five. ❤️ Bottom line: Lipid-lowering therapy is not broken just because you feel the same. It is not a short-term fix. It is a long-term investment in the vessel wall you cannot see. Stay on the medication. Recheck your labs. Judge this therapy in years, not months. That patience is what saves your life. Full breakdown of the VESALIUS-CV data here: https://dralo.net/blog/vesalius-repatha-all-cause-mortality Dr. Alo, America’s Cardiologist #Cardiology #HeartDisease #HeartHealth #CardiovascularHealth #Repatha #Statins #LDL #Cholesterol #PreventiveCardiology #LifestyleMedicine #MetabolicHealth
